What Does CT Urogram Check For?
CT urography (CTU) is a comprehensive imaging examination specifically designed to evaluate the entire urinary tract—including the kidneys, renal collecting systems, ureters, and bladder—primarily to detect urothelial malignancies, kidney stones, masses, and other urinary tract pathology. 1
Primary Clinical Indications
CTU serves as the preferred imaging modality for several key clinical scenarios:
Hematuria Evaluation
- CTU is the gold standard for evaluating gross hematuria and high-risk microhematuria, replacing older techniques like intravenous urography 1, 2
- Detects urothelial cell carcinoma with 96% sensitivity and 99% specificity 3
- Identifies renal cell carcinoma, bladder cancer, and upper urinary tract malignancies
- Evaluates urinary stones, which are the most common cause of hematuria 4
Urothelial Cancer Detection and Staging
- CTU is the most accurate modality for diagnosing and staging urothelial malignancies, both locally and for distant metastases 3
- Demonstrates 91% diagnostic accuracy in detecting urothelial cancers 3
- Essential for detecting synchronous tumors (multifocal disease occurs in 25-30% of upper tract urothelial cancers) 3
- Can identify spiculated margins and tissue invasion patterns that predict higher tumor stages 3
Technical Components
CTU is distinguished from standard CT abdomen/pelvis by its specialized protocol 1:
- Unenhanced phase: Evaluates kidney size, shape, position, and detects calculi without contrast interference 4
- Nephrographic phase (post-IV contrast): Optimal for visualizing renal parenchymal masses and assessing kidney enhancement 1, 4
- Excretory phase (≥5 minutes post-contrast): Evaluates the collecting systems, ureters, and bladder for urothelial abnormalities 1, 4
- Thin-slice acquisition with multiplanar reconstructions (maximum intensity projection, 3D volume rendering) 1
Specific Pathologies Detected
CTU comprehensively identifies:
- Malignancies: Urothelial carcinoma, renal cell carcinoma, bladder cancer
- Urolithiasis: Superior to all other modalities for stone detection and characterization 5
- Obstructive uropathy: Hydronephrosis, ureteral strictures (higher hydronephrosis grades predict advanced tumor stages) 3
- Trauma: Urinary tract injuries
- Infections: Pyelonephritis, abscess formation
- Vascular abnormalities: Though not the primary indication 4
- Congenital anomalies: Anatomic variants of the urinary tract
Key Advantages Over Alternative Imaging
CTU surpasses intravenous urography and other traditional methods because it 5:
- Visualizes small masses obscured by contrast or bowel gas on conventional urography
- Distinguishes enhancing tumors from non-enhancing blood clots or stones 3
- Evaluates non-functioning/obstructed kidneys that don't excrete contrast 3
- Provides cross-sectional imaging of surrounding abdominal organs 1
Important Clinical Caveats
- CTU may miss very small or flat urothelial lesions that require direct visualization with cystoscopy 3
- Cannot reliably distinguish between muscle-invasive (≥T2) and non-invasive (≤T1) tumors based on CT values alone 3
- Microscopic tumor invasion into surrounding tissue remains challenging to identify 3
- Patients with identified benign causes of microhematuria (vigorous exercise, infection, menstruation, recent procedures) do not benefit from CTU 1
The examination provides a single, comprehensive evaluation replacing multiple historical tests, making it the current standard for urinary tract imaging in appropriate clinical contexts 4, 2.